Business Wire

Helical Fusion Achieves Milestone Toward Commercial Fusion Energy, Advancing to Integrated Demonstration Device

27.10.2025 04:00:00 CET | Business Wire | Press release

Share

— World’s First Performance Test of a High-Temperature Superconducting Coil Under Conditions Replicating the Magnetic Environment Inside a Fusion Device —

Helical Fusion Co., Ltd., a world-leading developer of the Helical Stellarator, has completed a critical performance test of a high-temperature superconducting (HTS) coil—a core component of commercial fusion reactors. The company has now commenced manufacturing and construction of its integrated demonstration device, Helix HARUKA.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251026597002/en/

Helical Fusion members celebrating the successful HTS test with an “HTS Graduation!” sign and graduation caps

Watch the key points of this release in a 2-minute video: https://youtu.be/UhgQHfKtvow

Helical Fusion is the only company in the world building upon expertise in the Helical Stellarator approach, accumulated for more than 60 years at national institutes and national universities, which has been proven to possess the optimal characteristics for commercial power generation. As the sole inheritor of this knowledge from the National Institute for Fusion Science (NIFS), Helical Fusion is driving the Helix Program to realize the world’s first commercially viable fusion power plant using the Helical Stellarator.

Under the Helix Program, the company aims to complete performance tests of its two key technologies—HTS magnets and the integrated blanket/divertor system—by the end of the 2020s. By the 2030s, Helical Fusion plans to achieve full system integration through Helix HARUKA and begin steady-state power generation with its fusion pilot plant, Helix KANATA.

About the Performance Test

Significance

This milestone marks the world's first successful demonstration of an HTS coil constructed with a fully-functional large-scale conductor:

  1. The coil is based on a conductor cable designed for commercial fusion power plants' scale use 1
  2. The test replicated the magnetic environment inside a fusion device 2, including both self-generated and external magnetic fields
  3. Successfully conducted a current test under superconducting conditions

Using NIFS’s unique large-diameter, high-field testing facility, the conductor achieved stable superconducting current flow at 40 kA under a 7-tesla external magnetic field at 15 K (-258°C).

This result establishes Helical Fusion as one of the world’s leading contenders in the race toward commercial fusion energy and meets the technical threshold required to advance to the integrated demonstration device, Helix HARUKA.

Strong Collaboration with the National Laboratory and the Government

Since its founding in 2021, Helical Fusion has worked closely with NIFS through multiple joint research initiatives. In March 2024, a dedicated joint research team and lab space were established at NIFS to accelerate the development of HTS magnets and blanket/divertor systems - a model of Japan’s public-private partnership in fusion innovation.

The company’s progress is supported by Japan’s SBIR Phase 3 program, the first national grant scheme dedicated to fusion energy under the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The establishment of this program was strongly initiated by Ms. Sanae Takaichi, the current Prime Minister of Japan, during her tenure as Minister for the Cabinet Office, where she championed the inclusion of fusion energy as a national strategic priority. Helical Fusion received the program’s largest amount, JPY 2 billion (≒USD 13 million).

Importance of HTS Magnet Development

Fusion reactors require magnetic fields strong enough to confine plasma exceeding 100 million degrees Celsius. For commercial plants, these fields must be generated efficiently and compactly — a challenge that makes HTS technology indispensable.

While many companies produce HTS materials, only a few possess the capability to design and engineer full-scale superconducting systems for real reactor environments. Helical Fusion’s success demonstrates its technical leadership in this domain.

About the Helix Program

The Helix Program targets the launch of the world’s first commercially viable fusion power plant in the 2030s through its Fusion Pilot Plant, Helix KANATA. The program defines three essential requirements for commercially viable fusion power:

  1. Steady-state operation: 24/7/365 stable performance
  2. Net electricity output: generating more energy than it consumes
  3. Maintainability: regular, efficient component maintenance

Out of more than 50 fusion development projects worldwide—spanning tokamak and laser-based approaches—the Helical Stellarator is uniquely capable of meeting all three criteria with existing technologies. The Helix Program aims to be the world’s first initiative to realize all of these requirements by the 2030s.

Powered by a strong partnership with NIFS and supported by Japan's world-class manufacturing industry, Helical Fusion is committed to leading the global fusion energy sector—a market expected to reach trillions of dollars in scale in the coming decades.

Comment from Co-Founder, CEO Takaya Taguchi

This achievement is undoubtedly a remarkable laboratory milestone born from Japan’s strong collaboration between industry, government, and academia.

Yet, more importantly, it marks a global turning point — a moment when everyone pursuing or believing in commercial fusion must recognize Helical Fusion as one of the most promising contenders for realization.

I am immensely proud of our joint team with the National Institute for Fusion Science (NIFS) — the giant of fusion research from which our company originated — and deeply grateful to our Japanese manufacturing partners whose craftsmanship made this success possible.

As we move forward to the next stage, we invite the world to watch closely and share in the excitement of what comes next.

Comment from Co-Founder, CTO Junichi Miyazawa

The development of high-temperature superconducting (HTS) magnets marks a powerful shift from laboratory research to real-world implementation.

Over years of dedicated work, the global fusion community has advanced material and magnet technologies that did not even exist when I began our research — technologies that now give us strong confidence in achieving commercial fusion power.

This successful test is the culmination of many years of development and close collaboration with partners across academia and industry. We will channel our deepest gratitude into the continued progress of Helix HARUKA and Helix KANATA.

About Helical Fusion Co., Ltd.

Helical Fusion is a Japan-based startup developing the world’s first commercially viable net power fusion plant, leveraging the expertise of the Helical Stellarator and inheriting more than 60 years of national fusion research.

Helical Fusion has raised JPY 5.2 billion (≈USD 34 million) to date and targets commercial operation in the 2030s under its “Helix Program”.

 ___________________________________

1 This coil is made using advanced high-temperature superconducting (HTS) technology, and it was constructed without electrical insulation. Among all HTS coil technologies, this marks the world’s first successful test of uninsulated a large-scale HTS conductor-based coil.

2 “the magnetic environment inside a fusion device” refers to a setting in which external magnetic fields—separate from those generated by the coil itself—are present, creating complex electromagnetic interactions between multiple currents through the magnetic field. In future fusion power plants, such environments are expected to include intense radiation, neutron flux, and even stronger magnetic fields.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251026597002/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release

Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release

A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release

New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye